You are viewing an incomplete version of our website. Please click to reload the website as full version.

Hemagglutinin (HA) (N-Term) Peptide

Details for Product No. ABIN1004143, Supplier: Log in to see
Protein Name
Protein Region
N-Term
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-Hemagglutinin (HA) (N-Term) antibody (ABIN1002322)
Characteristics 15 amino acids near the amino terminus of Avian Influenza A (H5N1) hemagglutinin.
Application Notes The peptide is used for blocking the activity of the avian influenza hemagglutinin antibody . It usually blocks the antibody activity completely in ELISA assays by incubating the peptide with equal volume of antibody for 30 min at 37º
Restrictions For Research Use only
Format Liquid
Concentration 200 µg/mL
Buffer Supplied in PBS pH 7.2 (10 mM NaH₂PO₄, 10 mM Na₂HPO₄, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. The peptide solution should be gently mixed before use.
Storage -20 °C
Storage Comment Store at -20°C, stable for one year.
Expiry Date 12 months
Product cited in: Akira, Takeda: "Toll-like receptor signalling." in: Nature reviews. Immunology, Vol. 4, Issue 7, pp. 499-511, 2004 (PubMed).

Background publications Vogel, Fitzgerald, Fenton: "TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression." in: Molecular interventions, Vol. 3, Issue 8, pp. 466-77, 2004 (PubMed).

Deng, Wang, Spencer et al.: "Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain." in: Cell, Vol. 103, Issue 2, pp. 351-61, 2000 (PubMed).

Sancho, Vilá, Sánchez-Pulido et al.: "Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells." in: Molecular and cellular biology, Vol. 18, Issue 1, pp. 576-89, 1998 (PubMed).